Cocrystal Pharma Files 8-K: Updates and Former Names

Ticker: COCP · Form: 8-K · Filed: Apr 23, 2025 · CIK: 1412486

Cocrystal Pharma, INC. 8-K Filing Summary
FieldDetail
CompanyCocrystal Pharma, INC. (COCP)
Form Type8-K
Filed DateApr 23, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-disclosure, company-information

Related Tickers: COCP

TL;DR

Cocrystal Pharma (COCP) filed an 8-K on 4/23/25, updating corporate info and revealing past names.

AI Summary

Cocrystal Pharma, Inc. filed an 8-K on April 23, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The filing details the company's principal executive offices located at 19805 N. Creek Parkway, Bothell, WA 98011, and its telephone number is (876) 459-1831. The company was formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc.

Why It Matters

This filing provides essential corporate information and disclosures, including historical company name changes, which are important for understanding the company's evolution and current reporting status.

Risk Assessment

Risk Level: low — This filing is primarily administrative and informational, with no immediate financial or operational risks indicated.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Cocrystal Pharma, Inc.?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report on Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing was on April 23, 2025.

What is Cocrystal Pharma, Inc.'s principal executive office address?

Cocrystal Pharma, Inc.'s principal executive office is located at 19805 N. Creek Parkway, Bothell, WA 98011.

What were some of Cocrystal Pharma, Inc.'s former company names?

Cocrystal Pharma, Inc. was formerly known as BIOZONE PHARMACEUTICALS, INC. and International Surf Resorts, Inc.

What is the SEC file number for Cocrystal Pharma, Inc.?

The SEC file number for Cocrystal Pharma, Inc. is 001-38418.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 23, 2025 regarding Cocrystal Pharma, Inc. (COCP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing